# Executive Summary: Next-Step Evidence For Biological Countercurvature

## Data Provenance
- Date: 2026-02-16 (Authoritative snapshot)
- Source: `outputs/afcc/2026-02-16/metrics.csv`
- Scripts: `scripts/analysis/evidence_freshness_audit.py`, `scripts/analysis/confidence_weighted_structural_evidence.py`

## 1. What is stronger now than baseline?
- **Categorical rigor**: High-anisotropy predictions are now explicitly stratified by structural confidence (pLDDT).
- **Solid anchors**: We have confirmed that candidates like `CNNM2`, `PIEZO2`, and `ADGRG6` possess strong, high-confidence anisotropic structures (Anisotropy > 3.0, pLDDT > 70). These represent the most biologically defensible "tension rods" in our pipeline.
- **Data integrity awareness**: The freshness audit definitively identified static caching of AlphaFold data, allowing us to freeze false narrative drift regarding "evolving" structural geometries over time.

## 2. What remains weak?
- **The LBX1 Link**: `LBX1` remains a low-confidence (pLDDT = 66.9), intermediate-anisotropy candidate. Inferring direct mechanosensor functions purely from this static, low-confidence in-silico geometry is unsupported.
- **Low-confidence outliers**: Candidates like `POC5` (Anisotropy 24.69) and `GHR` (Anisotropy 5.13) have compelling scores but low structural confidence (< 70). They present a high risk of being computational artifacts (disordered regions modeled rigidly) rather than true biological structures.
- **Evidence AGAINST current hypothesis**: The static nature of the metrics and the high proportion of low-confidence predictions strongly weaken the blanket narrative that "high computational anisotropy equals biological mechanosensing." Much of the previous narrative around dynamic structural changes was not grounded in new data.

## 3. Top 3 Highest-Leverage Next Experiments
To transition from in-silico speculation to biological fact, the following experiments are critical:

1. **SMFS on High/Low Confidence Pairs**: Perform Single-Molecule Force Spectroscopy (SMFS) on a high-confidence extended target (e.g., PIEZO2 fragment or CNNM2) versus a low-confidence target (e.g., LBX1 or GHR) to test if the predicted architectures actually yield measurable mechanical resistance or unspool purely as disordered polymers.
2. **LINC Complex Dependency Assay (LBX1 Falsification)**: Measure LBX1 nuclear localization and activity in wild-type versus *LMNA*-null cells across different substrate stiffnesses. If localization is unchanged, the direct mechanosensor link via the nucleus is falsified.
3. **Orthogonal Structural Validation**: Use SAXS or cross-linking mass spectrometry (XL-MS) in crowded environments to validate whether the "blocky" domains of LBX1 exist as defined functional units in solution or behave as a random coil.
